Healthcare
InCarda Therapeutics
Upcoming June 04 2026
InCarda Therapeutics has created a new approach to treating A-fib at the moment patients need help most: when an episode begins
InCarda Therapeutics has created a new approach to treating A-fib at the moment patients need help most: when an episode begins
InCarda Therapeutics has created a new approach to treating A-fib at the moment patients need help most: when an episode begins
InCarda Therapeutics has created a new approach to treating A-fib at the moment patients need help most: when an episode begins
troCarWash has the potential to shorten operation times, improve outcomes, and reduce costs
4MINDS has launched the only AI platform that allows companies to build industry specific language models that are private
A precision neuroscience company developing treatments for children with epilepsy, autism, and other severe neurodevelopmental disorders
MadSci is developing the world’s first SmartShunt, that uses an intercranial fluid sensor to monitor and control a ICF pressure
Phio Pharmaceuticals (NASDAQ: PHIO) has developed a differentiated, precision approach to treating skin cancer.
A precision neuroscience company developing treatments for children with epilepsy, autism, and other severe neurodevelopmental disorders
Object Pharma is creating a novel, non-systemic neurotoxin platform to help solve today’s mental health crisis
troCarWash has the potential to shorten operation times, improve outcomes, and reduce costs
Phio Pharmaceuticals (NASDAQ: PHIO) has developed a differentiated, precision approach to treating skin cancer.